Blood test could predict vitiligo progression, study hopes
NCT ID NCT07298551
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study aims to create a model using a panel of 12 immune-signaling proteins (cytokines) in the blood to predict whether vitiligo will worsen or improve with treatment. Researchers will enroll 125 adults with vitiligo and a healthy comparison group. The goal is to find objective markers that help doctors choose the right treatment at the right time, reducing guesswork and improving outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xijing Hospital
Xi'an, Shannxi, 710032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.